These data show the clinical importance of SEMA3F, NRP1 and NRP2 in DCIS-to-IDC BC progression and correlate with the activation of EMT in IDC versus DCIS [37]. This evidence concerns the gene NRP1 and ductal breast carcinoma in situ.